Recombinant Human IL1RAP, N-His

Introduction

Recombinant Human IL1RAP, also known as Interleukin 1 Receptor Accessory Protein, is a protein that plays a crucial role in the immune system. It is a soluble protein that is involved in the regulation of inflammation and immune responses. Recombinant Human IL1RAP is produced through recombinant DNA technology, making it a highly pure and biologically active protein. In this article, we will discuss the structure, activity, and applications of Recombinant Human IL1RAP.

Structure of Recombinant Human IL1RAP

Recombinant Human IL1RAP is a glycosylated protein with a molecular weight of approximately 70 kDa. It is composed of 618 amino acids and contains a signal peptide at the N-terminus, followed by three extracellular immunoglobulin-like domains, a transmembrane domain, and a cytoplasmic domain. The extracellular domains are important for binding to its ligands, while the cytoplasmic domain is involved in signal transduction.

Activity of Recombinant Human IL1RAP

Recombinant Human IL1RAP is a co-receptor for the pro-inflammatory cytokines IL-1α and IL-1β. It works by binding to these cytokines and facilitating their interaction with the IL-1 receptor type I (IL-1RI). This interaction leads to the activation of downstream signaling pathways, resulting in the production of pro-inflammatory cytokines, chemokines, and other mediators of inflammation. Recombinant Human IL1RAP also plays a role in the activation of T cells and the differentiation of Th17 cells, which are important in the adaptive immune response.

Application of Recombinant Human IL1RAP

Recombinant Human IL1RAP has a wide range of applications in both research and clinical settings. Some of the key applications of this protein include:

1. Studying the role of IL1RAP in inflammation

Recombinant Human IL1RAP is commonly used in research to understand the role of this protein in inflammation and immune responses. It can be used to study the signaling pathways involved in IL1RAP-mediated inflammation and to investigate the effects of IL1RAP on different immune cells.

2. Development of therapeutic interventions for inflammatory diseases

Given its role in inflammation, Recombinant Human IL1RAP has potential as a therapeutic target for inflammatory diseases. Researchers are currently exploring the use of IL1RAP inhibitors for the treatment of conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

3. Diagnostic tool for autoimmune diseases

Autoimmune diseases are characterized by an overactive immune response, and IL1RAP has been implicated in the development of these conditions. Recombinant Human IL1RAP can be used as a biomarker for autoimmune diseases, aiding in their diagnosis and management.

4. Production of antibodies for IL1RAP detection

Recombinant Human IL1RAP can be used to produce monoclonal and polyclonal antibodies for the detection of this protein. These antibodies can be used in techniques such as ELISA, Western blotting, and immunohistochemistry to study IL1RAP expression in different tissues and cells.

5. Potential as a vaccine adjuvant

IL1RAP has been shown to enhance the immune response to vaccines, making it a potential adjuvant for vaccine development. Recombinant Human IL1RAP can be used to study its adjuvant properties and to develop more effective vaccines.

Conclusion

Recombinant Human IL1RAP is a key protein involved in inflammation and immune responses. Its structure, activity, and applications make it a valuable tool for studying the immune system and developing therapeutic interventions for inflammatory diseases. With ongoing research, we can expect to uncover more about the role of Recombinant Human IL1RAP and its potential in various fields of medicine.